In Vivo and In Vitro Comparison of the DPP-IV Inhibitory Potential of Food Proteins from Different Origins after Gastrointestinal Digestion

• Published in: International journal of molecular sciences 2022-07, Vol.23 (15), p.8365
• Main Authors: Fleury, Léa, Deracinois, Barbara, Dugardin, Camille, Nongonierma, Alice B, FitzGerald, Richard J, Flahaut, Christophe, Cudennec, Benoit, Ravallec, Rozenn
• Format: Article
• Language: English
• Subjects: Amino acids; Animals; bioactive peptides; Bioinformatics; Caco-2 Cells; Cattle; Diabetes; Diabetes mellitus (non-insulin dependent); Diabetes Mellitus, Type 2; dietary proteins; Digestion; Dipeptidyl Peptidase 4 - metabolism; Dipeptidyl-peptidase IV; Dipeptidyl-Peptidase IV Inhibitors - chemistry; Dipeptidyl-Peptidase IV Inhibitors - pharmacology; DPP-IV activity; Enzymes; Gelatin; Gene expression; Glucose; Glucose metabolism; Gluten; Hemoglobin; High performance liquid chromatography; Homeostasis; Humans; Hyperglycemia; in vitro gastrointestinal digestion; Insulin resistance; Life Sciences; Mass spectrometry; Mass spectroscopy; Nutrition; Oral administration; Origins; Ovalbumin; Peptidase; Peptidases; Peptides; Peptides - chemistry; peptidomics; Plasma; Proteins; Rats; Tandem Mass Spectrometry; type 2 diabetes; Whey
• ISSN: 1422-0067; 1661-6596; 1422-0067
• DOI: 10.3390/ijms23158365

Dipeptidyl-peptidase IV (DPP-IV) plays an essential role in glucose metabolism by inactivating incretins. In this context, food-protein-derived DPP-IV inhibitors are promising glycemic regulators which may act by preventing the onset of type 2 diabetes in personalized nutrition. In this study, the DPP-IV-inhibitory potential of seven proteins from diverse origins was compared for the first time in vitro and in vivo in rat plasma after the intestinal barrier (IB) passage of the indigested proteins. The DPP-IV-inhibitory potentials of bovine hemoglobin, caseins, chicken ovalbumin, fish gelatin, and pea proteins were determined in rat plasma thirty minutes after oral administration. In parallel, these proteins, together with bovine whey and gluten proteins, were digested using the harmonized INFOGEST protocol adapted for proteins. The DPP-IV half-maximal inhibitory concentration (IC ) was determined in situ using Caco-2 cells. The DPP-IV-inhibitory activity was also measured after IB passage using a Caco2/HT29-MTX mixed-cell model. The peptide profiles were analyzed using reversed-phase high-performance liquid chromatography tandem mass spectrometry (RP-HPLC-MS/MS) with MS data bioinformatics management, and the IC of the identified peptides was predicted in silico. The in vitro and in vivo DPP-IV-inhibitory activity of the proteins differed according to their origin. Vegetable proteins and hemoglobin yielded the highest DPP-IV-inhibitory activity in vivo. However, no correlation was found between the in vivo and in vitro results. This may be partially explained by the differences between the peptidome analysis and the in silico predictions, as well as the study complexity.